{"id":"extended-sequential-therapy","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This approach involves the sequential administration of different therapeutic modalities (such as chemotherapy, immunotherapy, or targeted agents) in a coordinated schedule rather than concurrently. The sequential design aims to maximize efficacy by allowing each treatment phase to exert its effect before transitioning to the next, potentially reducing toxicity and improving tolerability while maintaining or enhancing therapeutic benefit.","oneSentence":"Extended sequential therapy is a treatment regimen that combines multiple therapeutic agents administered in a planned sequence to optimize clinical outcomes.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:46:09.739Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07492914","phase":"PHASE2","title":"Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2026-03-20","conditions":"Resected Head and Neck Cancer","enrollment":30},{"nctId":"NCT05825066","phase":"PHASE2","title":"Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2023-08-01","conditions":"Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma","enrollment":64},{"nctId":"NCT06788548","phase":"NA","title":"Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2024-02-03","conditions":"Early Gastric Cancer","enrollment":312},{"nctId":"NCT07159841","phase":"PHASE2, PHASE3","title":"A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)","status":"RECRUITING","sponsor":"Crinetics Pharmaceuticals Inc.","startDate":"2026-01-22","conditions":"Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia","enrollment":153},{"nctId":"NCT05727189","phase":"PHASE1","title":"A Study of Idazoxan in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Terran Biosciences Australia Pty Ltd","startDate":"2023-02-14","conditions":"Healthy","enrollment":150},{"nctId":"NCT04273945","phase":"PHASE3","title":"Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Actelion","startDate":"2020-06-30","conditions":"Pulmonary Arterial Hypertension","enrollment":935},{"nctId":"NCT02991469","phase":"PHASE2","title":"A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2018-08-09","conditions":"Juvenile Idiopathic Arthritis","enrollment":51},{"nctId":"NCT07459881","phase":"NA","title":"Effects of Combined Upper Extremity Exercise and Pneumatic Compression Therapy on Breast Cancer-Related Lymphedema","status":"NOT_YET_RECRUITING","sponsor":"Far Eastern Memorial Hospital","startDate":"2026-03","conditions":"Breast Cancer Lymphedema","enrollment":20},{"nctId":"NCT05669950","phase":"PHASE1, PHASE2","title":"A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia","status":"RECRUITING","sponsor":"H. Lundbeck A/S","startDate":"2022-12-19","conditions":"Congenital Adrenal Hyperplasia","enrollment":42},{"nctId":"NCT07458711","phase":"NA","title":"Comparative Effects of Spencer Techniques and Movement With Mobilization in Improving Pain, Range of Motion, and Functional Disability in Rotator Cuff Syndrome.","status":"COMPLETED","sponsor":"University of Lahore","startDate":"2025-09-26","conditions":"Rotator Cuff Syndrome","enrollment":60},{"nctId":"NCT07459504","phase":"PHASE2","title":"SMART Diets for MASLD","status":"NOT_YET_RECRUITING","sponsor":"Corewell Health West","startDate":"2026-04-26","conditions":"Metabolic-dysfunction Associated Steatotic Liver Disease","enrollment":102},{"nctId":"NCT05144256","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period","status":"ACTIVE_NOT_RECRUITING","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2022-06-08","conditions":"Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia","enrollment":49},{"nctId":"NCT05101148","phase":"PHASE1","title":"Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-07-21","conditions":"Neurofibromatosis Type 1","enrollment":24},{"nctId":"NCT07423078","phase":"PHASE2","title":"Window of Opportunity in Preserving Laryngeal Function Trial","status":"NOT_YET_RECRUITING","sponsor":"Matthew Spector","startDate":"2026-03-31","conditions":"Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Locally Advanced Laryngeal Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma","enrollment":87},{"nctId":"NCT07418970","phase":"NA","title":"Effects of Action Observation Therapy in Geriatric Individuals","status":"COMPLETED","sponsor":"Hasan Kalyoncu University","startDate":"2025-01-01","conditions":"Cognitive Function, Balance Impairment, Fatigue","enrollment":162},{"nctId":"NCT06713174","phase":"NA","title":"Interleukin 8 and10 Levels Changes in Teeth With Necrotic Pulp and Apical Periodontitis","status":"COMPLETED","sponsor":"Faculty of Dental Medicine for Girls","startDate":"2024-12-15","conditions":"Pulp and Periapical Tissue Disease, Patients With Pulp Necrosis and Apical Periodontitis","enrollment":22},{"nctId":"NCT06156085","phase":"PHASE4","title":"Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy","status":"COMPLETED","sponsor":"Fu Jen Catholic University Hospital","startDate":"2023-11-14","conditions":"Helicobacter Pylori Infection","enrollment":337},{"nctId":"NCT06823765","phase":"NA","title":"Can Feedback From a Large Language Model Improve Health Care Quality?","status":"COMPLETED","sponsor":"Yale University","startDate":"2025-01-30","conditions":"All Conditions","enrollment":491},{"nctId":"NCT07362498","phase":"","title":"Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya","status":"COMPLETED","sponsor":"Strathmore University","startDate":"2020-06-01","conditions":"Malaria Falciparum","enrollment":316},{"nctId":"NCT05276297","phase":"PHASE2","title":"A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2022-03-22","conditions":"Hepatitis B, Chronic","enrollment":174},{"nctId":"NCT06433635","phase":"PHASE4","title":"Sequential Multiple Assignment Randomized Trial for Bipolar Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-10-01","conditions":"Bipolar I Disorder, Depression","enrollment":2726},{"nctId":"NCT07246668","phase":"PHASE2","title":"A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2025-03-10","conditions":"Hepatocellular Carcinoma, Liver Neoplasms, Carcinoma","enrollment":52},{"nctId":"NCT02918955","phase":"PHASE3","title":"Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2016-12-16","conditions":"Head and Neck Neoplasms","enrollment":65},{"nctId":"NCT04833907","phase":"PHASE1, PHASE2","title":"rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Myrtelle Inc.","startDate":"2021-04-01","conditions":"Canavan Disease","enrollment":24},{"nctId":"NCT04013802","phase":"PHASE1","title":"TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2021-03-08","conditions":"Viral Infection","enrollment":47},{"nctId":"NCT06379087","phase":"PHASE2","title":"Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC","status":"RECRUITING","sponsor":"Ji Yongling","startDate":"2024-05-01","conditions":"Non-Small Cell Lung Cancer","enrollment":20},{"nctId":"NCT07019272","phase":"","title":"Neratinib in Extended Adjuvant Treatment for HER2+ Early Breast Cancer With pCR But High-Risk Features: A Hebei Multi-Center Real-World Study","status":"NOT_YET_RECRUITING","sponsor":"Hebei Medical University Fourth Hospital","startDate":"2025-06-30","conditions":"HER2-positive Breast Cancer","enrollment":170},{"nctId":"NCT05867329","phase":"PHASE4","title":"Feasibility Pilot Sequential Multiple Assignment Randomized Trial (SMART) for Acute Severe Ulcerative Colitis","status":"RECRUITING","sponsor":"Berinstein, Jeffrey","startDate":"2023-09-30","conditions":"Ulcerative Colitis Acute","enrollment":162},{"nctId":"NCT03510325","phase":"PHASE3","title":"Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2019-02-12","conditions":"Schizophrenia","enrollment":762},{"nctId":"NCT06872606","phase":"PHASE2","title":"Short-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Sir Run Run Shaw Hospital","startDate":"2025-04-01","conditions":"Rectal Adenocarcinoma","enrollment":33},{"nctId":"NCT03109210","phase":"NA","title":"Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Jewish Health","startDate":"2017-04-15","conditions":"Insomnia, Primary, Sleep Apnea, Obstructive","enrollment":384},{"nctId":"NCT06801197","phase":"NA","title":"Impact of a Mobile App-Based Waitlist Intervention on Readiness for Eating Disorder Treatment","status":"NOT_YET_RECRUITING","sponsor":"University of British Columbia","startDate":"2025-02","conditions":"Eating Disorders","enrollment":74},{"nctId":"NCT06762158","phase":"NA","title":"NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC","status":"ACTIVE_NOT_RECRUITING","sponsor":"RenJi Hospital","startDate":"2024-10-30","conditions":"Esophageal Squamous Cell Carcinoma (ESCC)","enrollment":50},{"nctId":"NCT05621980","phase":"NA","title":"Finger Movement Training After Stroke","status":"RECRUITING","sponsor":"North Carolina State University","startDate":"2023-09-05","conditions":"Stroke","enrollment":36},{"nctId":"NCT02776735","phase":"PHASE2","title":"An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-09-06","conditions":"Juvenile Idiopathic Arthritis","enrollment":102},{"nctId":"NCT06638775","phase":"NA","title":"Functional Electrostimulation on the Upper Lip in Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"Universidad de Burgos","startDate":"2025-01-20","conditions":"Electrode Site Reaction, Therapy, Directly Observed Therapy","enrollment":30},{"nctId":"NCT06229665","phase":"PHASE2, PHASE3","title":"Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)","status":"ACTIVE_NOT_RECRUITING","sponsor":"LumiThera, Inc.","startDate":"2023-10-25","conditions":"Dry Age-related Macular Degeneration","enrollment":75},{"nctId":"NCT03689244","phase":"PHASE3","title":"A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment","status":"TERMINATED","sponsor":"Actelion","startDate":"2019-01-23","conditions":"Chronic Thromboembolic Pulmonary Hypertension","enrollment":128},{"nctId":"NCT01783535","phase":"PHASE2","title":"Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2013-06-19","conditions":"Retinoblastoma","enrollment":174},{"nctId":"NCT03466450","phase":"PHASE1, PHASE2","title":"Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma","status":"COMPLETED","sponsor":"Grupo Español de Investigación en Neurooncología","startDate":"2018-03-15","conditions":"Glioblastoma","enrollment":75},{"nctId":"NCT06109025","phase":"EARLY_PHASE1","title":"Improvement of Motor Imaginative Ability Through Functional Electrical Stimulation","status":"COMPLETED","sponsor":"Universidad de Burgos","startDate":"2023-10-01","conditions":"Electrode Site Reaction, Therapy, Directly Observed","enrollment":81},{"nctId":"NCT04613999","phase":"PHASE1","title":"A Study of Ralinepag in Healthy Chinese Adult Subjects","status":"COMPLETED","sponsor":"Everstar Medicines (Shanghai) Limited","startDate":"2020-10-09","conditions":"Healthy Volunteer, Pharmacokinetic Study","enrollment":15},{"nctId":"NCT05371249","phase":"PHASE4","title":"Vonoprazan-Based Triple Therapy in Comparison With Extended Sequential Therapy","status":"UNKNOWN","sponsor":"Fu Jen Catholic University Hospital","startDate":"2021-12-01","conditions":"Helicobacter Pylori","enrollment":628},{"nctId":"NCT02499835","phase":"PHASE1, PHASE2","title":"Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2015-07-01","conditions":"Hormone-Resistant Prostate Cancer, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Soft Tissues","enrollment":66},{"nctId":"NCT03502187","phase":"NA","title":"Subacute Low Back Pain in Active Duty","status":"COMPLETED","sponsor":"University of Tennessee","startDate":"2018-04-17","conditions":"Subacute Low Back Pain","enrollment":133},{"nctId":"NCT02604784","phase":"PHASE1, PHASE2","title":"Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancer and Primary Peritoneal Tumors","status":"COMPLETED","sponsor":"Fondazione del Piemonte per l'Oncologia","startDate":"2015-10","conditions":"Peritoneal Carcinomatosis","enrollment":105},{"nctId":"NCT01711515","phase":"PHASE1","title":"Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2012-10-01","conditions":"Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified","enrollment":34},{"nctId":"NCT03256331","phase":"PHASE1","title":"Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients","status":"TERMINATED","sponsor":"Belx Bio-Pharmaceutical (Taiwan) Corporation","startDate":"2017-06-21","conditions":"Advanced Solid Tumors","enrollment":23},{"nctId":"NCT02856035","phase":"NA","title":"Novel Brain Signal Feedback Paradigm to Enhance Motor Learning After Stroke","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2017-01-01","conditions":"Stroke","enrollment":4},{"nctId":"NCT02890992","phase":"PHASE2","title":"An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-09-15","conditions":"Hypercholesterolaemia","enrollment":42},{"nctId":"NCT03362723","phase":"PHASE1","title":"A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid Tumors","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2017-11-27","conditions":"Solid Tumors","enrollment":48},{"nctId":"NCT00578669","phase":"PHASE3","title":"Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms","status":"COMPLETED","sponsor":"Butler Hospital","startDate":"2008-04","conditions":"Major Depressive Disorder, Nicotine Dependence, Depression","enrollment":206},{"nctId":"NCT01446042","phase":"PHASE3","title":"Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism","status":"COMPLETED","sponsor":"Acerus Pharmaceuticals Corporation","startDate":"2011-09","conditions":"Male Hypogonadism","enrollment":306},{"nctId":"NCT03513198","phase":"","title":"Perfusion Assessment With Contrast-Enhanced EUS in Locally Advanced and Metastatic Pancreatic Cancer","status":"UNKNOWN","sponsor":"University of Medicine and Pharmacy Craiova","startDate":"2018-05-01","conditions":"Pancreas Cancer","enrollment":200},{"nctId":"NCT02044094","phase":"PHASE2","title":"Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder","status":"COMPLETED","sponsor":"Indivior Inc.","startDate":"2013-11","conditions":"Opioid Use Disorder","enrollment":39},{"nctId":"NCT01165541","phase":"PHASE2","title":"A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2010-09","conditions":"Alcohol Dependence","enrollment":20},{"nctId":"NCT02745912","phase":"PHASE1","title":"Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants","status":"COMPLETED","sponsor":"Orexigen Therapeutics, Inc","startDate":"2016-04","conditions":"Healthy Subjects","enrollment":30},{"nctId":"NCT01495169","phase":"PHASE1","title":"Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients","status":"COMPLETED","sponsor":"Vanda Pharmaceuticals","startDate":"2011-10","conditions":"Safety and Tolerability of Iloperidone","enrollment":33},{"nctId":"NCT01290471","phase":"PHASE1","title":"Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2011-01","conditions":"Advanced Solid Malignant Tumors, Advanced Ovarian Cancer","enrollment":36},{"nctId":"NCT01058213","phase":"PHASE2","title":"Nurse Managed Sequential Strength Training and Bicycle Training in Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2008-11","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":354},{"nctId":"NCT00303472","phase":"PHASE2","title":"Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)","status":"COMPLETED","sponsor":"Amgen","startDate":"2006-02","conditions":"Thrombocytopenia, MDS, Myelodysplastic Syndromes","enrollment":72},{"nctId":"NCT00620750","phase":"PHASE4","title":"Extended-release Naltrexone for Alcohol Dependence in Primary Care","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2007-07","conditions":"Alcohol Dependence","enrollment":72},{"nctId":"NCT00896155","phase":"PHASE3","title":"Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients","status":"UNKNOWN","sponsor":"Tata Memorial Hospital","startDate":"2008-12","conditions":"Pulmonary Fibrosis, Breast Cancer","enrollment":260}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["S-14"],"phase":"marketed","status":"active","brandName":"Extended sequential therapy","genericName":"Extended sequential therapy","companyName":"Fu Jen Catholic University Hospital","companyId":"fu-jen-catholic-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}